Cronos Group Inc (CRON)
$10.29
0.06 (0.59%)
CRON Stock Quote Delayed 15 Minutes
Previous Close
$10.29
Market Cap
1.81B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
3.14M
Day's Range
10.04 - 10.47
52-Week Range
6.50 - 25.10
Dividend & Yield
N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
Cronos Group Stock is Still Expensive Despite Allure of International Plans
To be fair, Cronos posted an increase in sales during the second quarter, but its negative cash flow position also rose and some analysts continue questioning the company's position in its home market of Canada.
Now Is Not the Time to Buy Cronos Stock
CRON stock looks unlikely to make any upward movement in the near term, making it a poor choice in the marijuana space right now.
Cronos Group Stock Continues to Lag as Canada Headwinds Hold Back Sector
Canadian headwinds are holding back Cronos Group stock as the next deregulation phase looms. Still CRON stock is doing better than peers.
Is Aurora Cannabis Stock a Buy Despite a Revenue Miss?
Throughout this year, marijuana-related investments like Aurora Cannabis stock took a massive beating. Still, markets work in cycles and with ACB not dropping to new lows, it suggests a possible turnaround is coming with the right catalyst.
3 Reasons Altria’s Investment in Cronos Group Stock Is Positive for CRON
CRON stock has suffered in recent days due to growing concern about vaping. But Altria should help CRON weather the storm.
Expect Cronos Stock to Fall as Losses Widen
Cronos management announced that EBITDA losses will likely widen in the second half of the year. Investors will see CRON stock fall further.
Stay Far Away From CRON Stock Until Its Valuation Comes Down
Many risks continue to make Cronos Group stock's valuation mind-boggling. Consider anything but CRON stock for a pot play.
Keep an Eye on Canopy Growth Stock, but Don’t Buy It Just Yet
Shares of Canopy Growth stock have been struggling immensely over the last few months. However, CGC has some new momentum.
Cronos Group Stock Suffers Sharply Amid Vaping Crisis
Although Cronos Group stock has the reputation for being the most stable of the cannabis players, it took a big dive on Monday. The reason why is likely due to serious concerns about the cannabis-based vaporizers, of which Cronos has a vested interest.
CRON Stock Will Require a Lot of Patience
Cronos is executing an interesting strategy - but it's a strategy that suggests limited catalysts for CRON stock in the near term.
Why Cronos Group Stock Stands Out in a Sea of Cannabis Sameness
CRON stock is off 50% since February, partly because investors see it like other, larger cannabis companies. Here's why Cronos Group stands out.
Hexo Stock Is Teetering on a Must-Hold Level
Throughout the entire legal marijuana industry, a sea of red ink plagues many competitors. However, HEXO has an extremely rich valuation. If the Hexo stock price doesn’t start showing upside momentum, it could be in for some real pain.
Dumping Acquisitions Could Signal More Bad News for ACB Stock
Aurora Cannabis stock is drifting lower for a reason, even of most investors are struggling to articulate it as earnings news nears.
Strong Fundamentals Make Cronos Stock a Value Play
CRON stock could continue to show strong revenue growth, making this dip a great buying opportunity in Cronos.
Expect the Transformation of Cronos Group to Change CRON Stock
For now, Cronos Group stock remains an extremely pricey marijuana play, despite its recent sharp losses. But in the long term, its backer Altria may mold and shape CRON into a cannabis version of itself.
Cronos Group’s Deal with Altria Presents ESG Concerns for CRON Stock
Cronos Group stock may not be attractive to institutions with ESG concerns. That is because its deal with Altria makes it a sin stock.
Stay Away From Cronos Stock Until Support Arrives
Cronos stock is fundamentally undervalued. But the technicals and optics are broken. Until they get unbroken, there won't be a big rebound.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
